Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. - Wikidata - wikimedia - TriplyDB

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

http://www.wikidata.org/entity/Q35050042

about

Bacteriophage Procurement for Therapeutic Purposes Genetically Engineered Phages: a Review of Advances over the Last Decade The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation Genome-editing Technologies for Gene and Cell Therapy Diversity of CRISPR-Cas immune systems and molecular machines Antimicrobial bacteriophage-derived proteins and therapeutic applications Current and future prospects for CRISPR-based tools in bacteria Alternatives to antibiotics in animal agriculture: an ecoimmunological view Bacteriophage-based tools: recent advances and novel applications Bacterial genome engineering and synthetic biology: combating pathogens CRISPR-Cas: biology, mechanisms and relevance Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems Synthetic biology to access and expand nature's chemical diversity Resistance and tolerance to foreign elements by prokaryotic immune systems - curating the genome Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy Neglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administration Mutations in Cas9 Enhance the Rate of Acquisition of Viral Spacer Sequences during the CRISPR-Cas Immune Response.Emergence and Evolution of Multidrug-Resistant Klebsiella pneumoniae with both blaKPC and blaCTX-M Integrated in Chromosome.Identifying and Visualizing Functional PAM Diversity across CRISPR-Cas Systems Ordering the mob: Insights into replicon and MOB typing schemes from analysis of a curated dataset of publicly available plasmids.Bacteriophages Contribute to the Spread of Antibiotic Resistance Genes among Foodborne Pathogens of the Enterobacteriaceae Family - A Review.Genomes by design.Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations.Cas9 specifies functional viral targets during CRISPR-Cas adaptation.Bacterial CRISPR: accomplishments and prospects.CRISPR-Cas immunity in prokaryotes.Conversion of embryonic stem cells into extraembryonic lineages by CRISPR-mediated activators.Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems.Applications of CRISPR technologies in research and beyond.A CRISPR design for next-generation antimicrobials.Insights from 20 years of bacterial genome sequencing.Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.Efficient Genome Editing in Clostridium cellulolyticum via CRISPR-Cas9 Nickase.Targeted DNA degradation using a CRISPR device stably carried in the host genome Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.Generation of Knock-In Pigs Carrying Oct4-tdTomato Reporter through CRISPR/Cas9-Mediated Genome Engineering.Manipulating Bacterial Communities by in situ Microbiome Engineering.High-throughput strategies for the discovery and engineering of enzymes for biocatalysis.CRISPR/Cas9-The ultimate weapon to battle infectious diseases?High Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in Cyprus

P2860

Q26738479-BBC44008-D16A-4649-B794-E76493A5B9CF Q26744156-79CF2201-5833-49D7-B9C6-560CF2A76642 Q26748672-05EF833C-19E7-40B7-AD6E-621BD96BA140 Q26769662-B0F9BD99-03C4-4213-8A7D-AE99A1079B55 Q26778564-5CCF3D96-253E-444A-9E38-7BB3B4A4CCB1 Q26781115-B310698B-B3E6-45EB-966E-F5EBABD51B36 Q26783837-9992655F-9A17-4FF9-8FAD-99C8316F958C Q26822258-DF900087-A4F3-4941-A1C6-787963FA70B7 Q28066480-FAC7A7ED-C406-4613-9FAE-188D8CF07872 Q28066540-87E94E0A-C2A2-422F-A818-D52A3A214D68 Q28069426-9965A312-7695-419E-9BFC-235D67A70ED3 Q28072295-66C609E6-812B-4F3F-94C9-66B853C8DFF3 Q28078320-88BEF192-C74D-4952-8F84-0C79FA01F022 Q28081298-6D869F61-684A-4109-9168-F570F346B108 Q28554197-3A3C64BC-9161-48EA-BE42-012D13654D66 Q28602660-36F22C90-FE93-4EB2-97C5-506364D66A22 Q30275154-B5DA950E-18B3-4C4B-A696-F964704D0BF8 Q30401330-17520395-F5D3-4592-8F3B-74D4A28C74AF Q30740166-C8A888BA-5337-4BD9-B73B-22BB105841C1 Q33783917-C981F5EE-6FE3-4B5E-92B3-3CE861706639 Q33813037-E3A27525-6930-43FE-8FA4-8C4136F6A2B8 Q33834503-4C325923-726E-4AE0-99AA-69DADE7A9ADF Q33853796-549CF2D3-2714-4C78-BDA9-1C476653527A Q34043239-58C37B98-BFB9-428D-AB59-477329B185EE Q34044882-16231DE2-AF04-4C5C-8D46-B3A572027664 Q34045076-2A159CC5-9A1D-4B26-96C3-8A4C23135781 Q34045868-69E21589-163C-4530-8DAF-D29C4C895D52 Q34536517-4E66887B-20C8-4591-8E0E-76490D2DFC1F Q34539796-D03DD3A3-436C-45DA-AA25-4FBABC8E7481 Q34803114-6B5D301F-83DD-4A29-9636-0C3240F0F8C9 Q35182581-2213CDF7-D411-478E-8534-FC26AB7ECDD7 Q35740389-5E73638B-A7BC-4069-98C3-743615C48708 Q35764115-C17C4E94-EE67-4951-A9B6-1D30BEBDC073 Q35775355-14AABB1E-7396-4A7E-B606-6B2FAF52CB14 Q35851888-47CCFBA0-7805-4594-AB60-BB28E4C11503 Q35891529-93AD211C-83CA-417C-858E-3F02EC625C8C Q35936180-B86C8784-4AD1-49B0-BEA0-BE8DB3BCEF1D Q36163361-83DF2821-D802-42B6-88F0-1191BDE51829 Q36196813-82A47469-B56F-480B-8E29-A65D0938FF19 Q36456613-4CCA63CD-6E41-4B86-8C4A-A88C1D82EAFE

P2860

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

http://www.wikidata.org/entity/Q35050042

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@ast

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@en

type

label

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@ast

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@en

prefLabel

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@ast

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@en

P1433

Q35050042-94F445D9-BF43-4888-B6EF-A64AB6756AEC

P1476

Q35050042-8EA5439C-4C4F-4ADF-8E23-DEB0463339FF

P2093

Q35050042-27C3A2CE-96AC-4416-8B32-96EE48761FDA

Q35050042-4A286D27-9FE7-4486-B880-550C433D7C18

Q35050042-5096DFF2-99F8-46FD-AB08-4DCD3554573C

Q35050042-6584C0C5-3929-4605-877B-4FF18BD22210

Q35050042-A85F03AC-A3ED-49A5-8687-ED31A97B4445

Q35050042-B2199A03-3F3E-4003-9871-13478D382541

Q35050042-F5FF34F1-DC82-4D98-A783-4C5DFA9B8567

P2860

Q35050042-0960A2D9-96C6-425B-BFC6-25F096D07AB4

Q35050042-0D1D89A4-EA9E-4850-8E9A-40ADC8B6321D

Q35050042-0EDDE6F6-D313-4ECF-9937-08D58D0882EE

Q35050042-1087BC71-E45B-4007-959A-26119E230C1E

Q35050042-1945D43C-50E4-429C-9546-295C2443C11F

Q35050042-242BF19F-A4DB-4B19-9E0B-5C6FB2BA02C0

Q35050042-2FA1FF47-E07E-4440-B366-4ACE6E85BC3C

Q35050042-51808E3A-F7D3-4D0B-B86D-AFA480E9A60E

Q35050042-5FA4C4E9-CC37-43A0-8704-1DF9972F9BFC

Q35050042-6536E1D8-F5B7-4DE3-B759-430A03E8A226

P2888

Q35050042-F0E4D3E6-379A-4FC6-9217-C7B323DB58FC

P304

Q35050042-31EB9E32-8528-426A-B6CB-15B7244AD7DE

P31

Q35050042-0A76D43A-F6B3-4246-B52B-38ABAFB7223E

P356

Q35050042-9063BE32-A22A-4C7A-9CD3-CF8C9E46B4DE

P433

Q35050042-9494309F-3617-4E35-8474-0ACFBA39A2B2

P478

Q35050042-E8C07ACB-9E21-41AF-AFD8-E8B8BBED8ED0

P50

Q35050042-B871C577-9367-4E59-8205-88AB4E3E9A33

P577

Q35050042-62221EFA-CA5F-47D5-A2BF-06CB3877FD7D

P5875

Q35050042-61E89FCC-C078-429B-B20E-3CF087131A1E

P698

Q35050042-D4E2E1D5-0F9E-4FC9-BB01-B0AF43F53781

P921

Q35050042-910B1484-28A8-4583-A7BC-0D9D7BF3B1C2

P932

Q35050042-AE63D493-0291-44D0-98D5-0D86008C5908

P356

P1433

Nature Biotechnology

P1476

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials.

@en

P2093

Chad W Euler

http://www.w3.org/2001/XMLSchema#string

Gregory W Goldberg

http://www.w3.org/2001/XMLSchema#string

Luciano A Marraffini

http://www.w3.org/2001/XMLSchema#string

Philip M Nussenzweig

http://www.w3.org/2001/XMLSchema#string

Vincent A Fischetti

http://www.w3.org/2001/XMLSchema#string

Wenyan Jiang

http://www.w3.org/2001/XMLSchema#string

Xavier Duportet

http://www.w3.org/2001/XMLSchema#string

P2860

CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III

RNA-guided editing of bacterial genomes using CRISPR-Cas systems

Topographical and temporal diversity of the human skin microbiome

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein

Staphylococcus aureus infections

Enzymatic assembly of DNA molecules up to several hundred kilobases

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands

A microbial symbiosis factor prevents intestinal inflammatory disease

P2888

P304

1146-1150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NBT.3043

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266580141

http://www.w3.org/2001/XMLSchema#string

P698

25282355

http://www.w3.org/2001/XMLSchema#string

P921

P932

4317352

http://www.w3.org/2001/XMLSchema#string